Drug intelligence / Profile preview

dithranol + tar

Development stage
Unknown
Modality
Small Molecules
Administration
Topical
01

Overview

Dithranol + tar is a topical combination therapy used primarily for the treatment of psoriasis. Dithranol (also known as anthralin or cignolin) acts by suppressing the proliferation of skin cells (keratinocytes), thereby reducing psoriatic plaques. Coal tar has anti-inflammatory, antipruritic, and keratoplastic properties and is also used to treat scaling and itching in various dermatological conditions. The combination of dithranol with coal tar (sometimes referred to as CSVT—cignolin-salicyl-vaseline plus tar) has been shown to reduce dithranol-induced erythema while increasing antipsoriatic efficacy compared to either agent alone[1][2]. This regimen is highly effective but may be less well tolerated due to staining and odor associated with both components[1]. The mechanism involves inhibition of DNA synthesis in epidermal cells (dithranol) and reduction of inflammation/itching via multiple pathways (coal tar)[6][3].

Other names
anthralin + coal tarcignolin + tarCSVT

Beyond the preview

Go deeper on dithranol + tar.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dithranol + tar.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call